Healthcare

Arkstone Expands Maternal Care with NeoSure™: Now Integrating Breastfeeding Safety into OneChoice ReportsArkstone Expands Maternal Care with NeoSure™: Now Integrating Breastfeeding Safety into OneChoice Reports

Arkstone Expands Maternal Care with NeoSure™: Now Integrating Breastfeeding Safety into OneChoice Reports

BOCA RATON, Fla., Feb. 13, 2025 /PRNewswire/ -- Arkstone, the leader in laboratory infectious disease guidance and antimicrobial stewardship, proudly…

2 days ago
Prominent Charleston Physician W. Melvin Brown, III, MD, Opens MDVIP-Affiliated Primary Care Practice on Upper PeninsulaProminent Charleston Physician W. Melvin Brown, III, MD, Opens MDVIP-Affiliated Primary Care Practice on Upper Peninsula

Prominent Charleston Physician W. Melvin Brown, III, MD, Opens MDVIP-Affiliated Primary Care Practice on Upper Peninsula

CHARLESTON, S.C. and BOCA RATON, Fla., Feb. 13, 2025 /PRNewswire/ -- MDVIP, the market leader in membership-based healthcare with a…

2 days ago
Lindus Health and CDISC Collaborate on Innovative AI Initiative to Standardize Clinical Trial Data for Accelerated ResearchLindus Health and CDISC Collaborate on Innovative AI Initiative to Standardize Clinical Trial Data for Accelerated Research

Lindus Health and CDISC Collaborate on Innovative AI Initiative to Standardize Clinical Trial Data for Accelerated Research

NEW YORK, Feb. 13, 2025 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials, has announced their…

2 days ago
Vitalchat Secures Series A Funding Led by GHC Industries to Scale Virtual Nursing and Telehealth SolutionsVitalchat Secures Series A Funding Led by GHC Industries to Scale Virtual Nursing and Telehealth Solutions

Vitalchat Secures Series A Funding Led by GHC Industries to Scale Virtual Nursing and Telehealth Solutions

RALEIGH, N.C., Feb. 13, 2025 /PRNewswire/ -- Vitalchat, an innovator of AI-powered ambient solutions for in-patient virtual nursing and procedural telehealth,…

2 days ago
Nabla Expands AI Offering with Dictation to Further Streamline Clinical WorkflowsNabla Expands AI Offering with Dictation to Further Streamline Clinical Workflows

Nabla Expands AI Offering with Dictation to Further Streamline Clinical Workflows

Nabla's co-development approach with clinicians informs and drives advances to existing dictation capabilities Voice-to-text Nabla Dictation works together with the…

2 days ago
Augustine Therapeutics appoints Gerhard Koenig as Chief Executive Officer as Company Prepares to Enter the ClinicAugustine Therapeutics appoints Gerhard Koenig as Chief Executive Officer as Company Prepares to Enter the Clinic

Augustine Therapeutics appoints Gerhard Koenig as Chief Executive Officer as Company Prepares to Enter the Clinic

Augustine Therapeutics appoints Gerhard Koenigas Chief Executive Officer as Company Prepares to Enter the Clinic Industry veteran Gerhard Koenig, PhD,…

2 days ago
RECORDATI: PRELIMINARY RESULTS FOR FULL YEAR 2024 REVENUE +12.4%, EBITDA(1) +12.5%, ADJUSTED NET INCOME(2) +8.4% PEAK YEAR SALES TARGETS RAISED FOR KEY RARE DISEASES PRODUCTSRECORDATI: PRELIMINARY RESULTS FOR FULL YEAR 2024 REVENUE +12.4%, EBITDA(1) +12.5%, ADJUSTED NET INCOME(2) +8.4% PEAK YEAR SALES TARGETS RAISED FOR KEY RARE DISEASES PRODUCTS

RECORDATI: PRELIMINARY RESULTS FOR FULL YEAR 2024 REVENUE +12.4%, EBITDA(1) +12.5%, ADJUSTED NET INCOME(2) +8.4% PEAK YEAR SALES TARGETS RAISED FOR KEY RARE DISEASES PRODUCTS

RECORDATI: PRELIMINARY RESULTS FOR FULL YEAR 2024 REVENUE +12.4%, EBITDA(1) +12.5%, ADJUSTED NET INCOME(2) +8.4%PEAK YEAR SALES TARGETS RAISED FOR…

2 days ago
Agios Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business HighlightsAgios Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

Agios Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

– Filed for Regulatory Approval of Mitapivat (PYRUKYND®) for the Treatment of Adult Patients with Non-Transfusion-Dependent and Transfusion-Dependent Alpha- or Beta-Thalassemia…

2 days ago
Veru Reports Fiscal 2025 First Quarter Financial Results and Clinical Program ProgressVeru Reports Fiscal 2025 First Quarter Financial Results and Clinical Program Progress

Veru Reports Fiscal 2025 First Quarter Financial Results and Clinical Program Progress

--Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary endpoint…

2 days ago
Teleflex Announces Fourth Quarter 2024 Earnings Conference Call InformationTeleflex Announces Fourth Quarter 2024 Earnings Conference Call Information

Teleflex Announces Fourth Quarter 2024 Earnings Conference Call Information

WAYNE, Pa., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its fourth…

2 days ago